These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 8701801

  • 1. Superficial bladder cancer--treatment approach.
    Abi-Aad A, Biquet P, Penders L.
    Acta Urol Belg; 1996 May; 64(2):19-24. PubMed ID: 8701801
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of bladder tumors].
    Njinou B, Dardenne B, Darimont M, Wese FX, Van Cangh PJ.
    Acta Urol Belg; 1999 May; 67(1):6-10. PubMed ID: 10859816
    [No Abstract] [Full Text] [Related]

  • 3. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F, Schuster F.
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [Abstract] [Full Text] [Related]

  • 4. BCG in the management of superficial bladder cancer.
    Guinan P, Richardson C, Hanna M, Rubenstein M.
    Prog Clin Biol Res; 1989 Aug; 303():447-53. PubMed ID: 2675002
    [Abstract] [Full Text] [Related]

  • 5. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP.
    Prog Clin Biol Res; 1992 Aug; 378():95-101. PubMed ID: 1301591
    [No Abstract] [Full Text] [Related]

  • 6. BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.
    Boccon-Gibod L.
    Prog Clin Biol Res; 1992 Aug; 378():55-7. PubMed ID: 1301586
    [No Abstract] [Full Text] [Related]

  • 7. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ.
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract] [Full Text] [Related]

  • 8. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 9. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
    Bouffioux C.
    Scand J Urol Nephrol Suppl; 1991 Nov; 138():167-77. PubMed ID: 1838428
    [No Abstract] [Full Text] [Related]

  • 10. When is a cystectomy necessary in carcinoma in situ?
    Herr HW.
    Prog Clin Biol Res; 1989 Nov; 303():511-5. PubMed ID: 2780659
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of superficial bladder cancer.
    Grossman HB.
    Compr Ther; 1995 May; 21(5):245-8. PubMed ID: 7621655
    [No Abstract] [Full Text] [Related]

  • 13. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
    Fujimoto K, Chihara Y, Kondo H, Hirao Y.
    Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
    [Abstract] [Full Text] [Related]

  • 14. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
    Lingnau A, Miller K, Steiner U, Jentzmik F, Weikert S, Schostak M.
    Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Definition and management of patients with bladder cancer who fail BCG therapy.
    Martin FM, Kamat AM.
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):815-20. PubMed ID: 19496718
    [Abstract] [Full Text] [Related]

  • 17. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S, Matsui Y, Takahashi T, Nishiyama H, Ito N, Yamamoto S, Kamoto T, Ogawa O.
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [Abstract] [Full Text] [Related]

  • 20. [ BCG-immunotherapy and bladder cancer].
    Rischmann P.
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.